We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.75B
AUM Growth
+$308M
Cap. Flow
-$43.6M
Cap. Flow %
-0.92%
Top 10 Hldgs %
20.23%
Holding
229
New
8
Increased
75
Reduced
111
Closed
9
Avg Time Held
3.3 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
2.4 years

Top Buys

Rank Stock Value
1
PARA icon
Paramount Global Class B
PARA
+$34.4M
2
UPS icon
United Parcel Service
UPS
+$30.9M
3
ADBE icon
Adobe
ADBE
+$29.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$15.5M
5
LLY icon
Eli Lilly
LLY
+$6.25M

Top Sells

Rank Stock Value
1
ALB icon
Albemarle
ALB
+$32.7M
2
CELG
Celgene Corp
CELG
+$27.3M
3
AMG icon
Affiliated Managers Group
AMG
+$25.5M
4
SCHW icon
Charles Schwab
SCHW
+$20.9M
5
FISV icon
Fiserv Inc
FISV
+$20M

Sector Composition

Rank Sector Weight
1 Technology 21.65%
2 Healthcare 19%
3 Consumer Discretionary 14.42%
4 Financials 13.75%
5 Industrials 13.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CB icon
26
Chubb
CB
$139B
$52.2M 1.1%
335,500
+60
+0% +$9.18K
2014 Q1
23 quarters
LH icon
27
Labcorp
LH
$25.8B
$51.8M 1.09%
356,388
-64
-0% -$9.24K
2016 Q1
15 quarters
SBUX icon
28
Starbucks
SBUX
$111B
$49.4M 1.04%
561,740
-85
-0% -$7.25K
2014 Q4
20 quarters
SNA icon
29
Snap-on
SNA
$19B
$48.3M 1.02%
284,875
-65
-0% -$10.6K
2013 Q2
26 quarters
PANW icon
30
Palo Alto Networks
PANW
$280B
$47.7M 1%
1,236,690
-330
-0% -$12.5K
2017 Q2
10 quarters
LLY icon
31
Eli Lilly
LLY
$1.12T
$45.8M 0.96%
348,325
+53,950
+18% +$6.25M
2019 Q3
1 quarter
SPGI icon
32
S&P Global
SPGI
$127B
$43.8M 0.92%
160,465
-25
-0% -$6.5K
2018 Q4
4 quarters
BSX icon
33
Boston Scientific
BSX
$64.3B
$42.4M 0.89%
937,885
+65
+0% +$2.72K
2018 Q1
7 quarters
META icon
34
Meta Platforms (Facebook)
META
$1.81T
$42.2M 0.89%
205,570
– –
2016 Q4
12 quarters
JPM icon
35
JPMorgan Chase
JPM
$902B
$42M 0.89%
301,465
-2,225
-0.7% -$285K
2018 Q3
5 quarters
IT icon
36
Gartner
IT
$13B
$41.9M 0.88%
271,725
+10,165
+4% +$1.55M
2016 Q4
12 quarters
KO icon
37
Coca-Cola
KO
$404B
$41.7M 0.88%
752,650
+90
+0% +$4.84K
2019 Q2
2 quarters
UNH icon
38
UnitedHealth
UNH
$360B
$41.6M 0.88%
141,580
+5,050
+4% +$1.32M
2019 Q3
1 quarter
PEP icon
39
PepsiCo
PEP
$179B
$39.5M 0.83%
288,920
-60
-0% -$8.17K
2013 Q2
26 quarters
MDLZ icon
40
Mondelez International
MDLZ
$81.6B
$39.4M 0.83%
714,525
-1,105
-0.2% -$59.1K
2017 Q3
9 quarters
BDX icon
41
Becton Dickinson
BDX
$52.2B
$38.9M 0.82%
146,483
-25
-0% -$6.23K
2018 Q2
6 quarters
HON icon
42
Honeywell
HON
$67B
$38.2M 0.81%
229,208
-42
-0% -$6.87K
2018 Q1
7 quarters
PARA icon
43
DELISTED
Paramount Global Class B
PARA
$37.3M 0.78%
+887,550
New +$34.4M
2019 Q4
0 quarters
MCD icon
44
McDonald's
MCD
$172B
$36.1M 0.76%
182,930
-30
-0% -$5.95K
2017 Q3
9 quarters
FISV icon
45
Fiserv Inc
FISV
$25.3B
$36M 0.76%
311,525
-180,963
-37% -$20M
2013 Q2
26 quarters
PFE icon
46
Pfizer
PFE
$169B
$35.5M 0.75%
956,141
+184
+0% +$6.55K
2013 Q2
26 quarters
AMGN icon
47
Amgen
AMGN
$234B
$35.1M 0.74%
145,420
-25
-0% -$5.51K
2018 Q2
6 quarters
ALC icon
48
Alcon
ALC
$32B
$34.6M 0.73%
612,055
+40,565
+7% +$2.32M
2019 Q2
2 quarters
ROK icon
49
Rockwell Automation
ROK
$47.3B
$34.6M 0.73%
170,495
-25
-0% -$4.63K
2018 Q2
6 quarters
GILD icon
50
Gilead Sciences
GILD
$194B
$34M 0.72%
523,675
+5,150
+1% +$335K
2013 Q2
26 quarters
1
2
3 4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q4 2019 Portfolio in Review

As of Q4 2019, Nicholas Company held 229 positions worth $4.75B, up 7% from $4.44B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Company's Q4 2019 filing shows 8 new, 75 increased, 111 reduced and 9 closed positions. Its largest new stake was Paramount Global Class B: 887,550 shares worth $37.3M. The largest sale was Albemarle, an estimated $32.7M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nicholas Company's largest Q4 2019 buy was Paramount Global Class B: 887,550 shares worth $37.3M.
  • Nicholas Company added most to Eli Lilly in Q4 2019, an estimated $6.25M increase.
  • Nicholas Company's biggest Q4 2019 reduction was Charles Schwab, cutting an estimated $20.9M.
  • Nicholas Company fully exited Albemarle in Q4 2019, selling an estimated $32.7M.
  • Nicholas Company's ten largest holdings make up 20% of its $4.75B portfolio in Q4 2019.
  • Nicholas Company opened 8 new positions and closed 9 in Q4 2019.
  • Nicholas Company's portfolio value rose 7% quarter-over-quarter to $4.75B.

Based on Nicholas Company's 13F filing for Q4 2019, filed 13 Feb 2020.